Who owns HALOZYME THERAPEUTICS?
- CUSIP Number: 40637had1
Tip: Access positions for across all investors
Analyze quarterly positions in Halozyme Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Halozyme Therapeutics stock
Who bought or sold HALOZYME THERAPEUTICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ing Investment Management | 211M | $202M | 8% | Dec 2024 |
|
| Linden Advisors | 84M | $80M | 100% | Dec 2024 |
|
| Wellesley Investment Advisors | 49M | $46B | 1% | Dec 2024 |
|
| Balyasny Asset Management | 38M | $37M | 100% | Dec 2024 |
|
| Lazard Asset Management | 36M | $34M | 0% | Dec 2024 |
|
| BlackRock | 33M | $31M | 6% | Dec 2024 |
|
| Camden Asset Management | 32M | $31B | -22% | Dec 2024 |
|
| Invesco | 29M | $28M | -50% | Dec 2024 |
|
| Calamos Advisors | 29M | $28M | -2% | Dec 2024 |
|
| Opti Capital Management | 25M | $24B | 100% | Dec 2024 |
|
| Tenor Capital Management | 23M | $22B | 100% | Dec 2024 |
|
| Advent Capital Management | 20M | $19M | -1% | Dec 2024 |
|
| State Street Corporation | 18M | $17M | 3% | Dec 2024 |
|
| Bank of America Corporation | 16M | $15M | 100% | Dec 2024 |
|
| Point72 Asset Management | 11M | $11M | 100% | Dec 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 9.5M | $9.0M | 0% | Dec 2024 |
|
| Jpmorgan Chase & Co | 7.7M | $7.4M | 28% | Dec 2024 |
|
| Shenkman Capital Management | 6.8M | $6.7B | -71% | Dec 2024 |
|
| Wells Fargo & Company | 6.5M | $6.2M | 40% | Dec 2024 |
|
| Sonora Investment Management Group | 4.1M | $3.9M | -1% | Dec 2024 |
|
| New York State Common Retirement Fund | 3.8M | $3.6M | 9% | Dec 2024 |
|
| FMR | 3.6M | $3.5M | 100% | Dec 2024 |
|
| Man Group | 3.1M | $3.0M | 0% | Dec 2024 |
|
| Water Island Capital | 3.0M | $2.9M | 100% | Dec 2024 |
|
| Palisade Capital Management | 2.6M | $2.5M | 0% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 2.5M | $2.4M | -69% | Dec 2024 |
|
| Flossbach Von Storch | 1.4M | $1.3M | -26% | Dec 2024 |
|
| Bank Of Montreal | 1.1M | $1.1M | -55% | Dec 2024 |
|
| Barclays | 663k | $633k | -40% | Dec 2024 |
|
| Bnp Paribas Investment Partners | 650k | $619k | 0% | Dec 2024 |
|
| Amundi | 324k | $320k | 0% | Dec 2024 |
|
| Leucadia National Corporation | 303k | $290k | -94% | Dec 2024 |
|
| Morgan Stanley | 285k | $272k | -37% | Dec 2024 |
|
| Calamos Wealth Management | 249k | $238k | -35% | Dec 2024 |
|
| KBC Group NV | 200k | $191k | 0% | Dec 2024 |
|
| Bank of New York Mellon | 200k | $191k | -71% | Dec 2024 |
|
| Union Investments & Development | 200k | $201k | 0% | Sep 2024 |
|
| Cetera Investment Advisers | 171k | $163k | -11% | Dec 2024 |
|
| Wiley Bros.-aintree Capital | 144k | $137k | 1% | Dec 2024 |
|
| CNH Partners | 140k | $134k | -99% | Dec 2024 |
|
| Cutler Capital Management | 110k | $105k | 0% | Dec 2024 |
|
| Argent Trust | 70k | $67k | 0% | Dec 2024 |
|
| SSI Investment Management | 62k | $59k | -98% | Dec 2024 |
|
| Mariner Wealth Advisors | 54k | $52k | 0% | Dec 2024 |
|
| Rollins Financial Advisors | 54k | $54k | 100% | Sep 2024 |
|
| Lake Street Advisors Group | 48k | $46k | 0% | Dec 2024 |
|
| Rsm Us Wealth Management | 47k | $45k | 0% | Dec 2024 |
|
| Foresight Capital Management Advisors | 35k | $33k | -10% | Dec 2024 |
|
| MAI Wealth Advisors | 19k | $18k | 100% | Dec 2024 |
|
| Ameriprise Financial | 18k | $17k | -100% | Dec 2024 |
|
| Nomura Holdings | 17k | $795k | 185% | Dec 2024 |
|
| Ronald Blue Trust | 16k | $15k | 100% | Dec 2024 |
|
| Goldstein Advisors | 14k | $13k | 0% | Dec 2024 |
|
| Citigroup | 14k | $13k | 100% | Dec 2024 |
|
| Wealth Enhancement Advisory Services | 10k | $10k | 100% | Dec 2024 |
|
| Brian McDonald | 10k | $9.5k | 0% | Dec 2024 |
|
| Laffer Investments | 2.0k | $2.0M | 3% | Dec 2024 |
|
| Northwestern Mutual Wealth Management Company | 2.0k | $1.9k | 100% | Dec 2024 |
|
| Nbc Securities | 13.00 | $12.000300 | -100% | Dec 2024 |
|
Who sold out of Halozyme Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Sep 2024 | 5.5M | $5.5M |
| Ubs Global Asset Management Americas | Sep 2024 | 4.7M | $4.7M |
| Toronto-Dominion Bank | Sep 2024 | 3.0M | $3.0M |
| Deutsche Bank Aktiengesellschaft | Sep 2024 | 1.4M | $1.4M |
| HPM Partners | Sep 2024 | 43k | $86k |
| Boussard & Gavaudan Investment Management | Sep 2024 | 13k | $13M |
| Candriam Luxembourg S.C.A. | Sep 2024 | 400.00 | $401k |